Table 1.
Baseline characteristics of the cohort (N = 523).
| Characteristics | Total | TG/HDL-c ratio (mmol/L) (quartiles) | P value | |||
|---|---|---|---|---|---|---|
| Q1 (<0.71) | Q2 (0.71-1.12) | Q3 (1.13-1.87) | Q4 (>1.89) | |||
| n | 523 | 131 | 130 | 131 | 131 | |
| Age (years) | 55.00 ± 11.74 | 57.71 ± 10.46 | 55.95 ± 12.05 | 52.54 ± 10.96 | 53.80 ± 12.81 | <0.001 |
| Female | 82 (15.68%) | 29 (22.14%) | 25 (19.23%) | 17 (12.98%) | 11 (8.40%) | 0.010 |
| BMI (kg/cm2) | 25.47 ± 3.87 | 24.65 ± 3.10 | 24.63 ± 4.25 | 26.91 ± 4.74 | 25.72 ± 2.80 | 0.291 |
| SBP | 150.73 ± 27.17 | 155.54 ± 27.35 | 149.07 ± 26.46 | 149.57 ± 26.10 | 148.67 ± 28.47 | 0.134 |
| DBP | 86.02 ± 16.18 | 87.56 ± 15.81 | 84.29 ± 14.85 | 87.06 ± 17.53 | 85.16 ± 16.37 | 0.312 |
| Smoking | 209 (39.96%) | 42 (32.06%) | 46 (35.38%) | 53 (40.46%) | 68 (51.91%) | 0.006 |
| DM | 25 (4.78%) | 9 (6.87%) | 2 (1.54%) | 11 (8.40%) | 3 (2.29%) | 0.020 |
| Hypertension | 386 (73.80%) | 85 (64.89%) | 90 (69.23%) | 99 (75.57%) | 112 (85.50%) | <0.001 |
| Stroke | 16 (3.06%) | 8 (6.11%) | 2 (1.54%) | 4 (3.05%) | 2 (1.53%) | 0.104 |
| Atherosclerosis | 51 (9.75%) | 11 (8.40%) | 10 (7.69%) | 12 (9.16%) | 18 (13.74%) | 0.345 |
| MFS | 5 (0.96%) | 1 (0.77%) | 1 (0.77%) | 2 (1.53%) | 1 (0.77%) | 0.529 |
| CRI | 16 (3.06%) | 1 (0.76%) | 4 (3.08%) | 7 (5.34%) | 4 (3.05%) | 0.201 |
| WBC (×109/L) | 10.92 ± 3.76 | 10.89 ± 3.23 | 11.41 ± 4.33 | 10.52 ± 3.49 | 10.88 ± 3.88 | 0.401 |
| PLT (×109/L) | 195.77 ± 78.14 | 165.81 ± 55.25 | 190.14 ± 61.16 | 210.46 ± 89.90 | 216.62 ± 89.90 | <0.001 |
| Hb (g/L) | 125.76 ± 20.60 | 126.84 ± 17.68 | 125.72 ± 21.36 | 125.63 ± 21.86 | 124.82 ± 21.43 | 0.923 |
| ALT (u/L) | 19.95 (13.50-33.38) | 16.60 (11.45-24.55) | 18.50 (13.03-28.70) | 23.30 (14.33-34.92) | 25.80 (16.10-51.30) | <0.001 |
| AST (u/L) | 19.50 (15.15-28.60) | 20.10 (15.75-26.15) | 18.20 (14.85-25.00) | 18.85 (14.85-26.28) | 22.45 (15.30-37.80) | 0.121 |
| Cr (umol/L) | 79.10 (65.45-103.88) | 72.30 (59.90-88.20) | 74.70 (63.30-102.20) | 76.20 (63.40-104.05) | 92.50 (73.50-122.20) | <0.001 |
| UA (mmol/L) | 317.49 ± 111.70 | 300.27 ± 105.43 | 332.41 ± 118.87 | 310.98 ± 103.98 | 326.31 ± 116.19 | 0.031 |
| TnT (pg/mL) | 7.83 (4.50-14.02) | 7.17 (4.59-9.68) | 7.46 (4.83-11.98) | 6.99 (3.66-13.57) | 9.87 (5.53-21.50) | 0.001 |
| TG (mmol/L) | 1.48 ± 0.85 | 0.71 ± 0.19 | 1.06 ± 0.22 | 1.53 ± 0.43 | 2.63 ± 0.72 | <0.001 |
| HDL-c (mmol/L) | 1.19 ± 0.32 | 1.46 ± 0.33 | 1.20 ± 0.22 | 1.06 ± 0.26 | 1.03 ± 0.26 | <0.001 |
| Operation | 0.003 | |||||
| No | 117 (22.37%) | 37 (28.24%) | 14 (10.77%) | 32 (24.43%) | 34 (25.95%) | |
| Yes | 406 (77.63%) | 94 (71.76%) | 116 (89.23%) | 99 (75.57%) | 97 (74.05%) | |
| Mortality | <0.001 | |||||
| Survivor | 490 (93.69%) | 129 (98.47%) | 126 (96.92%) | 121 (92.37%) | 114 (87.02%) | |
| Nonsurvivor | 33 (6.31%) | 2 (1.53%) | 4 (3.08%) | 10 (7.63%) | 17 (12.98%) | |
Abbreviations: BMI: body mass index; SBP: systolic blood pressure; DBP: diastole blood pressure; WBC: white blood cells count; PLT: platelet count; Hb: hemoglobin; ALT: alanine transaminase; AST: aspartate aminotransferase; Cr: creatinine; UA: uric acid; TnT: troponin T; DM: diabetes mellitus; MFS: Marfan syndrome; CRI: chronic renal insufficiency; TG: triglyceride; HDL-c: high-density lipoprotein cholesterol.